FDA Approval of LYNPARZA® in US for HRR gene-mutated mCRPC
Josefa Briceno, M.D., Medical Head for the DNA Damage Response Franchise in US Medical Affairs at AstraZeneca discusses the recent FDA approval of LYNPA...
5306 articles
Josefa Briceno, M.D., Medical Head for the DNA Damage Response Franchise in US Medical Affairs at AstraZeneca discusses the recent FDA approval of LYNPA...
Geoffrey Eubank, M.D., Medical Director of the Mid Ohio MS Center at OhioHealth Neurological Physicians, discusses 2 Phase lll clinical trials of Enspry...
John Lewis, Ph.D., CEO of Aegis Life, Inc., a spinout of Entos Pharmaceuticals, discusses the company's goal of developing a novel DNA vaccine using its...
Caron Jacobson, MD, Clinical Director, Immune Effector Cell Therapy Program, Dana-Farber Cancer Institute discusses the blood cancers lymphoma and leuke...
Pam Nisevich Bede, a registered dietitian from Abbott, a global healthcare company and leader in nutrition science, discusses how to get “nutrition st...
Glen de Vries, co-CEO and co-founder of Medidata, the most-used platform for clinical trials around the world, shares insights from his new book coming ...
Bryan Witherbee, CEO of Adarza Biosystems discusses ZIVA™, a label-free protein detection platform that can accurately test 100s of protein from a sin...
Kendra Grubb, surgical director of the Emory Structural Heart and Valve Center in Atlanta discusses data from a national survey released by patient advo...
John Martin, CMO of Butterfly Network discusses Butterfly iQ, the world's first handheld, single-probe, whole-body ultrasound system that is making ultr...
Brian Culley, CEO of Lineage Cell Therapeutics, a clinical-stage biotechnology company, discusses the three cell therapy programs they currently have in...